Lido Advisors, LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 176 filers reported holding HERON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
Lido Advisors, LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$40,618
-5.2%
39,435
+6.8%
0.00%
Q2 2023$42,845
-19.6%
36,935
+4.6%
0.00%
-100.0%
Q1 2023$53,315
-39.6%
35,3080.0%0.00%0.0%
Q4 2022$88,270
-40.4%
35,3080.0%0.00%
-50.0%
Q3 2022$148,000
+51.0%
35,3080.0%0.00%
+100.0%
Q2 2022$98,000
-51.2%
35,3080.0%0.00%
-50.0%
Q1 2022$201,000
+17.5%
35,308
+88.5%
0.00%0.0%
Q4 2021$171,000
-14.5%
18,7320.0%0.00%
-33.3%
Q3 2021$200,000
-31.3%
18,7320.0%0.00%
-25.0%
Q2 2021$291,00018,7320.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders